Cited by 649Schizophrenia research and treatmentMental Health and PsychiatryBipolar Disorder and Treatment

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Natural Course of Schizophrenic Disorders: A 15-Year Followup of a Dutch Incidence Cohort

Wiersma, D., Nienhuis, F. J., Slooff, C. J., Giel, R.·1998·Schizophrenia Bulletin

DOI 10.1093/oxfordjournals.schbul.a033315

Open this paper in CoChat — free account

Abstract

Data are presented on the 15-year natural course of schizophrenia and other nonaffective functional psychoses in a cohort of 82 first-contact cases from a circumscribed area in the Netherlands. The subjects were suffering from functional psychosis with International Classification of Diseases-Ninth Revision (ICD-9) diagnoses 295, 297, or 298.3-9 (broad definition of schizophrenia) on entry. Standardized assessments of psychopathology, psychological impairments, negative symptomatology, social disability, and use of mental healthcare were used. The study reveals a pattern of chronicity and relapses with a high risk of suicide: Two-thirds of the subjects had at least one relapse and after each relapse 1 of 6 subjects did not remit from the episode; 1 of 10 committed suicide; and 1 of 7 had at least one episode with affective psychotic symptoms that started on average 6 years after the onset of the schizophrenic disorder. Diagnoses were reclassified in five patients, according to DSM-III-R criteria for a bipolar disorder. The predictive power--in terms of time in psychosis and in partial or full remission--of demographic, illness, and treatment variables at onset of the illness was very limited. Insidious onset and delays in mental health treatment are risk factors that predict a longer duration of first or subsequent episodes. The importance of mental health treatment in regard to outcome is probably subject to change because an early warning and intervention strategy could prevent further damage and deterioration. Our data support the need for an adequate relapse prevention program as a priority for our mental health services.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1093/oxfordjournals.schbul.a033315

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
DSM-IV: Diagnostic and Statistical Manual of Mental Disorders
Bell, C. C. (1994) · JAMA · doi:10.1001/jama.1994.03520100096046 · Cited by 2,608
Book Review: Measurement and Classification of Psychiatric Symptoms
Priest, R. G. (1975) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591577506800751 · Cited by 2,268
Schizophrenia: manifestations, incidence and course in different cultures A World Health Organization Ten-Country Study
Jablensky, A., Sartorius, N., Ernberg, G., Anker, M., Korten, A., Cooper, J. E., Day, R., & Bertelsen, A. (1992) · Psychological Medicine. Monograph Supplement · doi:10.1017/s0264180100000904 · Cited by 1,769
Neuroleptics and the Natural Course of Schizophrenia
Wyatt, R. J. (1991) · Schizophrenia Bulletin · doi:10.1093/schbul/17.2.325 · Cited by 787
One hundred years of schizophrenia: a meta-analysis of the outcome literature
Hegarty, J. D., Baldessarini, R. J., Tohen, M. F., WATERNAUX, C. M., & Oepen, G. (1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.10.1409 · Cited by 771
A Selective Review of Recent North American Long-term Followup Studies of Schizophrenia
McGlashan, T. H. (1988) · Schizophrenia Bulletin · doi:10.1093/schbul/14.4.515 · Cited by 551
Search for the Causes of Schizophrenia
(1995) · Springer eBooks · doi:10.1007/978-3-642-79429-2 · Cited by 510
Schizophrenia : manifestations, incidence and course in different cultures
Zhablenski, A. V. (1992) · Cambridge University Press eBooks · Cited by 506
Time Course and Biologic Correlates of Treatment Response in First-Episode Schizophrenia
Lieberman, J. A. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820170047006 · Cited by 446

Show all 38 references

Research works printed but not linked: 4

Eaton, W.W.; Bilker, W.; Haro, J.M.; Hen-man, H.; Mortensen, P.B.; Freeman, H.; and Burgess, P. Long-term course of hospitalization for schizophrenia: Part II. Change with passage of time. Schizophrenia Bulletin, 18(2):229-241, 1992.
Engelhardt, D.M.; Rosen, B.; Feldman, J.; Engelhardt, J.A.; and Cohen, P. A 15-year follow-up of 646 schizo- phrenic outpatients. Schizophrenia Bulletin, 8(3):493- 503, 1982.
Hogarty, G.E. Prevention of relapse in schizophrenia. Journal of Clinical Psychiatry, 54(Suppl. 3):18-23, 1993.
Wing, J.K.; Cooper, J.E.; and Sartorius, N. The Measure- ment and Classification of Psychiatric Symptoms. Cambridge, England: Cambridge University Press, 1974.

Sorted by citations

Items 301–400 of 644

Early sustained recovery following first episode psychosis: Evidence from the AESOP10 follow-up study
Lappin, J., Heslin, M., Lomas, B., Jones, P. B., Doody, G. A., Reininghaus, U., Croudace, T. J., Craig, T., Fearon, P., Murray, R. M., et al. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.03.014 · Cited by 17
Early recovery and employment outcome 13 years after first episode psychosis
Strålin, P., Skott, M., & Cullberg, J. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.12.013 · Cited by 17
Exploration of Treatment-Resistant Schizophrenia Subtypes Based on a Survey of 204 US Psychiatrists
Correll, C. U., Brevig, T., & Brain, C. (2019) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s234813 · Cited by 17
Development and external validation of an admission risk prediction model after treatment from early intervention in psychosis services
Puntis, S., Whiting, D., Pappa, S., & Lennox, B. (2021) · Translational Psychiatry · doi:10.1038/s41398-020-01172-y · Cited by 17
Targeting Personal Recovery of People With Complex Mental Health Needs: The Development of a Psychosocial Intervention Through User-Centered Design
van der Meer, L., Jonker, T., Wadman, H., Wunderink, C., van Weeghel, J., Pijnenborg, G. H. M., & van Setten, E. R. H. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.635514 · Cited by 17
Development of the Korea-Polyenvironmental Risk Score for Psychosis
Jeon, E., Kang, S. H., Piao, Y. H., Kim, S., Kim, J., Lee, B. J., Yu, J., Lee, K. Y., Won, S., Lee, S., et al. (2022) · Psychiatry Investigation · doi:10.30773/pi.2021.0328 · Cited by 18
Clinical outcomes of long‐acting risperidone in recent versus long‐term diagnosed B elgian schizophrenic patients: results from electronic S chizophrenia T reatment A dherence R egistry ( e ‐ STAR ) and T rial for the I nitiation and M aintenance Of RE mission in S chizophrenia with risperidone ( TIMORES )
Dubois, V., Peuskens, J., Geerts, P., & Detraux, J. (2013) · Early Intervention in Psychiatry · doi:10.1111/eip.12017 · Cited by 17
Perceived risk of relapse and role of medication: comparison between patients with psychosis and their caregivers
Chan, S. K. W., Wong, M. H. M., Hui, C. L. M., Lee, E. H. M., Chang, W. C., & Chen, E. Y. H. (2014) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-014-0930-0 · Cited by 17
Proceedings of the Tenth International Workshop on Health Text Mining and Information Analysis (LOUHI 2019)
(2019) · doi:10.18653/v1/d19-62 · Cited by 17
Rate and predictors of disengagement from a 2-year early intervention program for psychosis in Hong Kong
Chan, T. C. W., Chang, W. C., Hui, C. L. M., Chan, S. K. W., Lee, E. H. M., & Chen, E. Y. H. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.01.033 · Cited by 16
Adherence, persistence, and inpatient utilization among adult schizophrenia patients using once-monthly versus twice-monthly long-acting atypical antipsychotics
Pilon, D., Alcusky, M. J., Xiao, Y., Thompson‐Leduc, P., Lafeuille, M., Lefèbvre, P., & Benson, C. J. (2017) · Journal of Medical Economics · doi:10.1080/13696998.2017.1379413 · Cited by 16
Active psychosis and pro-inflammatory cytokines in first-episode of psychosis
de Santayana, G. P., Juncal‐Ruíz, M., Vázquez-Bourgón, J., Riesco-Dávila, L., de la Foz, V. O., Pelayo‐Terán, J. M., López‐Hoyos, M., & Crespo‐Facorro, B. (2020) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2020.12.060 · Cited by 16
Achieving better outcomes for schizophrenia patients in Hong Kong: Strategies for improving treatment adherence
Lo, W. T.-L., Mak, K., Wong, M. M. C., Chan, O., Chui, E., Chung, D. W.-S., Ip, G., Lau, K., Lee, C., Mui, J. H. C., et al. (2021) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13375 · Cited by 15
“Long-acting” olanzapine in maintenance therapy of schizophrenia: A study with plasma levels
Mauri, M. C., Maffini, M., Pace, C. D., Reggiori, A., Paletta, S., Moliterno, D., Rovera, C., & Altamura, C. A. (2014) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651501.2014.1000928 · Cited by 16
Clinical Staging in the Pathophysiology of Psychotic and Affective Disorders: Facilitation of Prognosis and Treatment
Archer, T., Kostrzewa, R. M., Palomo, T., & Beninger, R. J. (2010) · Neurotoxicity Research · doi:10.1007/s12640-010-9161-7 · Cited by 16
The Role of Early Warning Symptoms in the Detection and Prevention of Relapse in Schizophrenia
Fitzgerald, P. B. (2001) · Australian & New Zealand Journal of Psychiatry · doi:10.1046/j.1440-1614.2001.00962.x · Cited by 16
Aripiprazole once-monthly long-acting injectable for the treatment of schizophrenia
Potkin, S., & Preda, A. (2016) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.1114100 · Cited by 17
Duration of untreated psychosis
Marshall, M., Harrigan, S., & Lewis, S. W. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511576287.009 · Cited by 16
Prevalence of long‐term mental health care utilization in The Netherlands
Wiersma, D., Sytema, S., Busschbach, J. J. V., Schreurs, M. J., Kroon, H., & Driessen, G. (1997) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1997.tb10159.x · Cited by 16
Self-citation
Relapse prevention through health technology program reduces hospitalization in schizophrenia
Homan, P., Schooler, N. R., Brunette, M. F., Rotondi, A. J., Ben‐Zeev, D., Gottlieb, J. D., Mueser, K. T., Achtyes, E. D., Gingerich, S. L., Marcy, P., et al. (2022) · Psychological Medicine · doi:10.1017/s0033291722000794 · Cited by 15
Diminished treatment response in relapsed versus first-episode schizophrenia as revealed by a panel of blood-based biomarkers: A combined cross-sectional and longitudinal study
Cai, H., Zeng, C., Zhang, X., Liu, Y., Wu, R., Guo, W., Wang, J., Wu, H., Tang, H., Ge, X., et al. (2022) · Psychiatry Research · doi:10.1016/j.psychres.2022.114762 · Cited by 16
Patient Perspectives on AI-Driven Predictions of Schizophrenia Relapses: Understanding Concerns and Opportunities for Self-Care and Treatment
Yoo, D. W., Woo, H., Nguyen, V. C., Birnbaum, M. L., Kruzan, K. P., Kim, J. G., Abowd, G. D., & Choudhury, M. D. (2024) · CHI Conference on Human Factors in Computing Systems · doi:10.1145/3613904.3642369 · Cited by 23
Clinical outcomes of long-acting injectable risperidone in patients with schizophrenia: six-month follow-up from the Electronic Schizophrenia Treatment Adherence Registry in Latin America
Apiquián, R., Córdoba, R., & Louzã, M. R. (2010) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s15911 · Cited by 15
Accumulation rate of advanced glycation end products in recent onset psychosis: A longitudinal study
Hagen, J. M., Sutterland, A. L., Edrisy, S., Tan, H. L., & de Haan, L. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.113192 · Cited by 15
Predictors of Hospitalization Two Years After Treatment for First-Episode Psychosis
Turner, M. A., Boden, J. M., & Mulder, R. (2013) · Psychiatric Services · doi:10.1176/appi.ps.201200388 · Cited by 15
Outcome in males with first-episode schizophrenia: 7-year follow-up
Češková, E., Přikryl, R., & Kašpárek, T. (2010) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2010.518625 · Cited by 15
Early intervention in schizophrenia
Kulhara, P., Banerjee, A., & Dutt, A. (2008) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.42402 · Cited by 15
Integrated treatment of schizophrenia
Altamura, A. C., Fagiolini, A. M., Galderisi, S., Rocca, P., & Rossi, A. (2015) · Use Siena air (University of Siena) · Cited by 14
Which atypical antipsychotic for schizophrenia?
(2004) · Drug and Therapeutics Bulletin · doi:10.1136/dtb.2004.42857 · Cited by 15
Early Intervention for psychosis
Marshall, M., & Lockwood, A. (2003) · doi:10.1002/14651858.cd004718 · Cited by 15
An Intelligent Cloud-Based Platform for Effective Monitoring of Patients with Psychotic Disorders
Maglogiannis, I. G., Zlatintsi, A., Menychtas, A., Papadimatos, D., Filntisis, P. P., Efthymiou, N., Retsinas, G., Tsanakas, P. D., & Maragos, P. A. (2020) · IFIP advances in information and communication technology · doi:10.1007/978-3-030-49186-4_25 · Cited by 12
The Natural Course of Schizophrenia and Psychopathological Predictors of Outcome
Michele, V. D., & Bolino, F. (2004) · Psychopathology · doi:10.1159/000078090 · Cited by 14
The Concept of Schizophrenia: From Unity to Diversity
Häfner, H. (2014) · Advances in Psychiatry · doi:10.1155/2014/929434 · Cited by 18
Cognitive behavior therapies for psychotic disorders: Current empirical status and future directions
Gaudiano, B. A. (2005) · Clinical Psychology: Science and Practice · doi:10.1093/clipsy/bpi004 · Cited by 87
The polygenic basis of relapse after a first episode of schizophrenia.
Segura, À., Prohens, L., Gassó, P., Rodríguez, N., García-Rizo, C., Moreno-Izco, L., Andreu-Bernabeu, Á., Zorrilla, I., Mané, A., Rodríguez-Jiménez, R., et al. (2023) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2023.06.003 · Cited by 14
The prediction of discharge from in-patient psychiatric rehabilitation: a case-control study
Bredski, J., Watson, A., Mountain, D. A., Clunie, F. S., & Lawrie, S. M. (2011) · BMC Psychiatry · doi:10.1186/1471-244x-11-149 · Cited by 13
Cognitive Behavioral Therapy Across the Stages of Psychosis: Prodromal, First Episode, and Chronic Schizophrenia
Valmaggia, L., Tabraham, P., Morris, E. M. J., & Bouman, T. K. (2008) · Cognitive and Behavioral Practice · doi:10.1016/j.cbpra.2007.02.007 · Cited by 13
Use of Benzodiazepines and Antipsychotic Drugs Are Inversely Associated With Acute Readmission Risk in Schizophrenia
Strømme, M. F., Mellesdal, L. S., Bartz-Johannesen, C. A., Kroken, R. A., Krogenes, M. L., Mehlum, L., & Johnsen, E. (2021) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001497 · Cited by 13
Preventing EPISODE II: relapse prevention in first-episode psychosis
Gleeson, J. (2005) · Australasian Psychiatry · doi:10.1080/j.1440-1665.2005.02198.x · Cited by 14
Schizophrenia relapse, patient considerations, and potential role of lurasidone
Citrome, L. (2016) · Patient Preference and Adherence · doi:10.2147/ppa.s45401 · Cited by 13
Rate of and time to symptomatic remission in first-episode psychosis in Northern Malawi
Kaminga, A. C., Dai, W., Liu, A., Myaba, J., Banda, R., Wen, S. W., & Pan, X. (2018) · Medicine · doi:10.1097/md.0000000000013078 · Cited by 14
Psychiatrists' opinion towards medication discontinuation in remitted first‐episode psychosis: A multi‐site study of the Asian Network for Early Psychosis
Hui, C., Wong, A. K., Leung, W., Lee, E., Chan, S., Chang, W., Chen, E., Chan, T. C., Swapna, V., Tagata, H., et al. (2018) · Early Intervention in Psychiatry · doi:10.1111/eip.12765 · Cited by 13
Very Long-Term Outcome of Community-Dwelling Patients With Schizophrenia Spectrum Disorders in Rural Greece
Peritogiannis, V., Grammeniati, A., Gogou, A., Gioti, P., & Mavreas, V. G. (2019) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0000000000001068 · Cited by 13
Economic consequences of alternative medication strategies in first episode non-affective psychosis
Stant, A. D., TenVergert, E. M., Wunderink, L., Nienhuis, F. J., & Wiersma, D. (2007) · European Psychiatry · doi:10.1016/j.eurpsy.2007.02.003 · Cited by 13
Self-citation
Outpatient vs. comprehensive first-episode psychosis services, a 5-year follow-up of Soteria Nacka
Lindgren, I., Hogstedt, M. F., & Cullberg, J. (2006) · Nordic Journal of Psychiatry · doi:10.1080/08039480600937686 · Cited by 13
Effectiveness, efficiency and efficacy in the multidimensional treatment of schizophrenia: Rethinking project
Crespo‐Facorro, B., Bernardo, M., Argimón, J. M., Arrojo, M., Bravo‐Ortiz, M. F., Cabrera-Cifuentes, A., Román, J. C., Franco, M., García‐Portilla, M. P., Haro, J. M., et al. (2017) · Revista de Psiquiatría y Salud Mental (English Edition) · doi:10.1016/j.rpsmen.2016.09.002 · Cited by 13
Implementing a self‐management model of relapse prevention for psychosis into routine clinical practice
stevens, S., & Sin, J. (2005) · Journal of Psychiatric and Mental Health Nursing · doi:10.1111/j.1365-2850.2005.00840.x · Cited by 13
Maintenance Treatment
Marder, S. R., & Wirshing, D. A. (2003) · doi:10.1002/9780470987353.ch25 · Cited by 13
Antipsychotics and structural brain changes: could treatment adherence explain the discrepant findings?
Emsley, R. A. (2023) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253231195258 · Cited by 12
Antipsychotic Use and Psychiatric Hospitalization in First-Episode Non-affective Psychosis and Cannabis Use Disorder: A Swedish Nationwide Cohort Study
Denissoff, A., Taipale, H. T., Tiihonen, J., Forti, M. D., Mittendorfer‐Rutz, E., Tanskanen, A. J., Mustonen, A., & Niemelä, S. (2024) · Schizophrenia Bulletin · doi:10.1093/schbul/sbae034 · Cited by 13
Use of Benzodiazepines and Antipsychotic Drugs Are Inversely Associated with Acute Readmission Risk in Schizophrenia
Strømme, M. F., Mellesdal, L., Bartz-Johannessen, C., Kroken, R. A., Krogenes, M. L., Mehlum, L. I., & Johnsen, E. (2022) · NORA - Norwegian Open Research Archives · Cited by 12
Development of an individualized risk calculator of treatment resistance in patients with first-episode psychosis (TRipCal) using automated machine learning: a 12-year follow-up study with clozapine prescription as a proxy indicator
Wong, T. Y., Luo, H., Tang, J. Y. ‐., Moore, T. M., Gur, R. C., Suen, Y. N., Hui, C. L. M., Lee, E. H. M., Chang, W. C., Yan, W. C., et al. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-02754-w · Cited by 12
Study on psychoeducation enhancing results of adherence in patients with schizophrenia (SPERA-S): study protocol for a randomized controlled trial
Петретто, Д. Р., Preti, A., Zuddas, C., Veltro, F., Rocchi, M., Sisti, D., Martinelli, V., Carta, M. G., Masala, C., & on behalf of the SPERA-S group (2013) · Trials · doi:10.1186/1745-6215-14-323 · Cited by 12
Critical appraisal of 3-monthly paliperidone depot injections in the treatment of schizophrenia
Carpiniello, B., & Pinna, F. (2016) · Drug Design Development and Therapy · doi:10.2147/dddt.s86301 · Cited by 12
Factors related to improvement of symptoms, function, and caregiver burden in Chinese patients with schizophrenia after switching to paliperidone palmitate once-monthly from oral antipsychotics
Li, N., Feng, Y., Lu, H., Cai, S. L., Zhuo, J., Si, T., & Zhang, L. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s158353 · Cited by 12
The Early Youth Engagement in first episode psychosis (EYE-2) study: pragmatic cluster randomised controlled trial of implementation, effectiveness and cost-effectiveness of a team-based motivational engagement intervention to improve engagement
Greenwood, K., Webb, R., Gu, J., Fowler, D. G., de Visser, R. O., Bremner, S. A., Abramowicz, I., Perry, N., Clark, S., O’Donnell, A., et al. (2021) · Trials · doi:10.1186/s13063-021-05105-y · Cited by 12
Suicidal behavior in schizophrenia and schizoaffective disorder
Harkavy‐Friedman, J., Nelson, E. A., & Venarde, D. F. (2001) · Clinical Neuroscience Research · doi:10.1016/s1566-2772(01)00036-6 · Cited by 12
Homesick: residential and care patterns in patients with severe mental illness
de Mooij, L. D., Kikkert, M., Lommerse, N. M., Theunissen, J., de Koning, M. B., de Haan, L., Beekman, A. T. F., Duurkoop, P. W. R. A., & Dekker, J. (2016) · BMC Psychiatry · doi:10.1186/s12888-016-1137-6 · Cited by 12
First psychosis prodrome: Rehabilitation and recovery.
Chovil, I. (2005) · Psychiatric Rehabilitation Journal · doi:10.2975/28.2005.407.410 · Cited by 12
Acute Pharmacological Treatment of Schizophrenia
Miyamoto, S., Stroup, T. S., Duncan, G. E., Aoba, A., & Lieberman, J. A. (2003) · Wiley eBooks · doi:10.1002/9780470987353.ch24 · Cited by 12
Guidelines for Discontinuation of Antipsychotics in Patients Who Recover From First-Episode Schizophrenia Spectrum Disorders: Derived From the Aggregated Opinions of Asian Network of Early Psychosis Experts and Literature Review
Asian Network of Early Psychosis Writing Group, Hui, C. L. M., Chen, E. Y. H., Verma, S., Tagata, H., Mizuno, M., Liu, C., Takeuchi, H., Kim, S., & Chung, Y. (2022) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyac002 · Cited by 11
Symptomatic, functional and quality of life measures of remission in 194 outpatients with schizophrenia followed naturalistically in a 6-month, non-interventional study of aripiprazole once-monthly
Correll, C. U., Brieden, A., & Janetzky, W. (2023) · Schizophrenia · doi:10.1038/s41537-023-00405-5 · Cited by 14
Assessing the Efficacy of Clinical Sentiment Analysis and Topic Extraction in Psychiatric Readmission Risk Prediction
Mellado, E. Á., Holderness, E., Miller, N., Dhang, F., Cawkwell, P. B., Bolton, K. W., Pustejovsky, J. D., & Hall, M. (2019) · International Workshop on Health Text Mining and Information Analysis (LOUHI) · doi:10.18653/v1/d19-6211 · Cited by 11
Qualitative investigation of targets for and barriers to interventions to prevent psychosis relapse
Eisner, E., Barrowclough, C., Lobban, F. A., & Drake, R. (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-201 · Cited by 12
Algorithm‐based pharmacotherapy for first‐episode schizophrenia involuntarily hospitalized: A retrospective analysis of real‐world practice
Yoshimura, B., Sato, K., Takaki, M., & Yamada, N. (2017) · Early Intervention in Psychiatry · doi:10.1111/eip.12442 · Cited by 11
Impact of crime victimization on initial presentation to an early intervention for psychosis service and 18‐month outcomes
Fisher, H. L., Roberts, A., Day, F., Reynolds, N., Iacoponi, E., Garety, P. A., Craig, T., McGuire, P. K., Valmaggia, L., & Power, P. (2015) · Early Intervention in Psychiatry · doi:10.1111/eip.12219 · Cited by 11
Non-adherence and its consequences: understanding the nature of relapse
Emsley, R. A. (2013) · World Psychiatry · doi:10.1002/wps.20067 · Cited by 11
Once-monthly paliperidone palmitate in early stage schizophrenia – a retrospective, non-interventional 1-year study of patients with newly diagnosed schizophrenia
Emsley, R. A., Hargarter, L., Bergmans, P., Uglešić, B., Şengül, A. C., Petralia, A., Khannanova, A. N., Chérubin, P., & Schreiner, A. (2017) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s142634 · Cited by 11
Relapse Prevention in Early Psychosis
Gumley, A. I., & Park, C. (2010) · Wiley eBooks · doi:10.1002/9781444318814.ch18 · Cited by 11
Working memory deterioration as an early warning sign for relapse in remitted psychosis: A one-year naturalistic follow-up study
Tao, T. J., Hui, C. L. M., Hui, P. W. M., Ho, E. C. N., Lam, B. S. T., Wong, A. K. H., See, S. H. W., Chan, E. W. T., Suen, Y. N., Lee, E. H. M., et al. (2022) · Psychiatry Research · doi:10.1016/j.psychres.2022.114976 · Cited by 9
Research on interpersonal violence in schizophrenia: based on different victim types
He, Y., Gu, Y., Yu, M., Li, Y., Li, G., & Hu, Z. (2022) · BMC Psychiatry · doi:10.1186/s12888-022-03820-7 · Cited by 11
Hospitalization risk factors in antipsychotic-treated schizophrenia, bipolar I disorder or major depressive disorder
Yan, T., Greene, M., Chang, E. Y., Broder, M. S., Touya, M., Munday, J., & Hartry, A. (2018) · Journal of Comparative Effectiveness Research · doi:10.2217/cer-2018-0090 · Cited by 10
Factores Pronósticos de Esquizofrenia en Primer Episodio Psicótico
Cano, J. F., Urresta, M. F., Vanegas, C., Alzate, M., Olarte, A. M., Cendales, R., & Córdoba, R. N. (2007) · Revista de Salud Pública · doi:10.1590/s0124-00642007000300014 · Cited by 10
Empirically Based Psychosocial Therapies for Schizophrenia: The Disconnection between Science and Practice
Shean, G. D. (2013) · Schizophrenia Research and Treatment · doi:10.1155/2013/792769 · Cited by 10
Body mass index and mental health problems in general adults: Disparity in gender and socioeconomic status
Hu, H., Wu, C., Chou, Y., & Huang, N. (2012) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2012.01.007 · Cited by 10
Significance of morphological features in schizophrenia of a Chinese population
Huang, C., Chiu, H.-J., Lan, T., Wang, H., Kuo, S.-W., Chen, S.-F., Yu, Y.-H., Liu, Y., Hu, T., & Loh, E. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.06.004 · Cited by 10
Atypical course in severe catatonic schizophrenia in a cannabis-dependent male adolescent: a case report
Håkansson, A., & Johansson, B. A. (2015) · Journal of Medical Case Reports · doi:10.1186/s13256-015-0678-5 · Cited by 10
The role of maintenance pharmacotherapy in achieving recovery from a first episode of schizophrenia
Tauscher‐Wisniewski, S., & Zipursky, R. B. (2002) · International Review of Psychiatry · doi:10.1080/0954026021000016923 · Cited by 10
Preventing disease progression in schizophrenia: What are we waiting for
Lieberman, J. A., Mendelsohn, A. I., Goldberg, T. E., & Emsley, R. A. (2024) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2024.12.042 · Cited by 9
Relapse prediction using wearable data through convolutional autoencoders and clustering for patients with psychotic disorders
Yan, A. Y., Speed, T. J., & Taylor, C. O. (2025) · Scientific Reports · doi:10.1038/s41598-025-03856-1 · Cited by 11
White-matter connectivity related to paliperidone treatment response in patients with schizophrenia
Kim, M., Kim, B., Lee, K. S., Kim, C. M., Bang, S. Y., Choi, T. K., & Lee, S. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881115625114 · Cited by 9
Oxford Handbook of Clinical Specialties
Baldwin, A., Hjelde, N., Goumalatsou, C., & Myers, G. (2016) · doi:10.1093/med/9780198719021.001.0001 · Cited by 9
Preventing Relapse of Psychotic Illness
Hewitt, L., & Birchwood, M. J. (2002) · Disease Management & Health Outcomes · doi:10.2165/00115677-200210070-00001 · Cited by 9
Pharmacological strategies for relapse prevention in schizophrenia
Barnes, T. R. E., & Drake, R. (2007) · Psychiatry · doi:10.1016/j.mppsy.2007.07.002 · Cited by 9
Duration of untreated psychosis: What are we talking about?
Polari, A. R., Berk, M., Macneil, C. A., & Conus, P. (2009) · Acta Neuropsychiatrica · doi:10.1111/j.1601-5215.2009.00380.x · Cited by 9
NEUROCOGNITIVE PROFILES OF PATIENTS WITH THE FIRST EPISODE OF PSYCHOSIS AND SCHIZOPHRENIA DO NOT DIFFER QUALITATIVELY: A NESTED CROSS-SECTIONAL STUDY
Kuharić, D. B., Makarić, P., Kekin, I., Bajić, Ž., Živković, M., Savić, A., Jukić, V., & Kuzman, M. R. (2019) · Psychiatria Danubina · doi:10.24869/psyd.2019.43 · Cited by 9
Should CBT Target the Social Impairments Associated With Schizophrenia?
Roberts, D. L., Penn, D. L., Cather, C., Otto, M. W., & GOFF, D. C. (2004) · Journal of Cognitive Psychotherapy · doi:10.1891/088983904780935540 · Cited by 10
The physical health and premature mortality of Indigenous Māori following first-episode psychosis diagnosis: A 15-year follow-up study
Monk, N. J., Cunningham, R., Stanley, J., Crengle, S. M., Fitzjohn, J., Kerdemelidis, M., Lockett, H., McLachlan, A., Waitoki, W., & Lacey, C. J. (2024) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/00048674241270981 · Cited by 8
Accuracy of machine learning methods in predicting prognosis of patients with psychotic spectrum disorders: a systematic review
Tay, J. L., Ang, Y. L., Tam, W., & Sim, K. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-084463 · Cited by 10
Long term course and outcome of first episode schizophrenia: a 27-to-31-year follow-up
Baltazar, L., Benedictis, L. D., Abdel‐Baki, A., Lalonde, P., & LESAGE, A. D. (2021) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-021-02185-8 · Cited by 8
Impact de la durée de psychose non traitée sur la qualité de vie et les fonctions cognitives
Rebhi, H., Damak, R., Chérif, W., Ellini, S., Cheour, M., & Ellouze, F. (2018) · L Encéphale · doi:10.1016/j.encep.2017.12.006 · Cited by 8
Perspective on medication decisions following remission from first-episode psychosis
Hui, C. L. M., Lam, B. S. T., Lee, E. H. M., Chan, S. K. W., Chang, W. C., Suen, Y. N., & Chen, E. Y. H. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.02.007 · Cited by 10
Beyond the first episode: Candidate factors for a risk prediction model of schizophrenia
Murphy, B. (2010) · International Review of Psychiatry · doi:10.3109/09540261003661833 · Cited by 7
Therapeutic Drug Monitoring of Second-Generation Antipsychotics for the Estimation of Early Drug Effect in First-Episode Psychosis: A Cross-sectional Assessment
Bustillo, M., Zabala, A., Querejeta, I., Carton, J. I., Mentxaka, O., González-Pinto, A. M., García, S., Meana, J. J., Eguíluz, J. I., & Segarra, R. (2018) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000480 · Cited by 8
Population Pharmacokinetics of Paliperidone Palmitate (Once‐Monthly Formulation) in Japanese, Korean, and Taiwanese Patients With Schizophrenia
Shimizu, H., Neyens, M., Meulder, M. D., Gopal, S., Tsukamoto, Y., Samtani, M. N., & Remmerie, B. M. M. (2019) · Clinical Pharmacology in Drug Development · doi:10.1002/cpdd.737 · Cited by 8
Ziprasidone and Migraine Headache
Boeker, T. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.8.1435-a · Cited by 8
Zotepine versus placebo for schizophrenia
Dickenson, R., & Fenton, M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010644 · Cited by 7
Genome-wide association analysis to predict optimal antipsychotic dosage in schizophrenia: a pilot study
Koga, A., Strauss, J., Zai, C. C. H., Remington, G. J., & Luca, V. D. (2016) · Journal of Neural Transmission · doi:10.1007/s00702-015-1472-7 · Cited by 7
Early interventions for prodromal stage of psychosis
Bošnjak, D., Kekin, I., Hew, J., & Kuzman, M. R. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012236 · Cited by 7
Specialised early intervention teams for first episode psychosis
Puntis, S., Minichino, A., Crescenzo, F. D., Cipriani, A., & Lennox, B. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013288 · Cited by 7

Authors: Wiersma, D., Nienhuis, F. J., Slooff, C. J., & Giel, R.
Affiliations: University of Groningen (NL)
Corresponding author: Wiersma, D.
ORCID: Giel, R.
Venue: Schizophrenia Bulletin
Publisher: Oxford University Press (OUP)
Published: 1998-01-01
Volume: 24
Issue: 1
Pages: 75-85
ISSN: 0586-7614 (ISSN-L)
1745-1701
DOI: 10.1093/oxfordjournals.schbul.a033315
OpenAlex: W2121119246
Cited by: 649
References: 38
Citations by year: 2026: 8 · 2025: 12 · 2024: 14 · 2023: 14 · 2022: 18 · 2021: 17 · 2020: 56 · 2019: 38 · 2018: 24 · 2017: 26 · 2016: 62 · 2015: 22 · 2014: 34 · 2013: 28 · 2012: 15
FWCI: 8.73
Type: journal article
Language: en
Open access: closed
Locations: Schizophrenia Bulletin (publishedVersion)
PubMed (publishedVersion)
University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion)
University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
Keywords: schizophrenia
MeSH terms: Suicide Prevention, Activities of Daily Living, Adolescent, Adult, Chronic Disease, Female, Follow-Up Studies, Humans, Male, Middle Aged, Netherlands, Psychiatric Status Rating Scales, Recurrence, Rehabilitation, Vocational, Schizophrenia, Schizophrenic Psychology, Suicide, Cohort Studies, Incidence, Disease Progression

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Natural Course of Schizophrenic Disorders: A 15-Year Followup of a Dutch Incidence Cohort

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks